IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing small molecule therapies for NASH.
Industry: Health Care
Latest Trade: $6.66 0.00 (0.0%)
First Day Return: +8.2%
Return from IPO: -60.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/15/2021 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $128 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/04/2021 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $128 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
Goldman Sachs |
more |
Company Data | |
---|---|
Headquarters | Foster City, CA, United States |
Founded | 2016 |
Employees | 30 |
Website www.ternspharma.com |